In CRC tissues and cells, reduced RBM4 expression led to relatively high levels of Nova1−4 transcripts which were greater than upregulated expressions of total Nova1 mRNAs, subsequently enhancing the migratory activity of CRC cells. The gene discussed is NOVA1; the disease is colorectal carcinoma.